midlands private neurophysiology ltd Company Information
Company Number
07181095
Next Accounts
Dec 2025
Shareholders
noushad shereef mytheen
mini noushad
View AllGroup Structure
View All
Industry
Specialist medical practice activities
Registered Address
9 courtney place, bowdon, altrincham, WA14 3QT
Website
-midlands private neurophysiology ltd Estimated Valuation
Pomanda estimates the enterprise value of MIDLANDS PRIVATE NEUROPHYSIOLOGY LTD at £1.7m based on a Turnover of £3.8m and 0.43x industry multiple (adjusted for size and gross margin).
midlands private neurophysiology ltd Estimated Valuation
Pomanda estimates the enterprise value of MIDLANDS PRIVATE NEUROPHYSIOLOGY LTD at £1m based on an EBITDA of £347.1k and a 2.98x industry multiple (adjusted for size and gross margin).
midlands private neurophysiology ltd Estimated Valuation
Pomanda estimates the enterprise value of MIDLANDS PRIVATE NEUROPHYSIOLOGY LTD at £4.4m based on Net Assets of £2m and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Midlands Private Neurophysiology Ltd Overview
Midlands Private Neurophysiology Ltd is a live company located in altrincham, WA14 3QT with a Companies House number of 07181095. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in March 2010, it's largest shareholder is noushad shereef mytheen with a 40% stake. Midlands Private Neurophysiology Ltd is a established, small sized company, Pomanda has estimated its turnover at £3.8m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Midlands Private Neurophysiology Ltd Health Check
Pomanda's financial health check has awarded Midlands Private Neurophysiology Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs


5 Strong

1 Regular

4 Weak

Size
annual sales of £3.8m, make it larger than the average company (£501.5k)
- Midlands Private Neurophysiology Ltd
£501.5k - Industry AVG

Growth
3 year (CAGR) sales growth of 25%, show it is growing at a faster rate (7.6%)
- Midlands Private Neurophysiology Ltd
7.6% - Industry AVG

Production
with a gross margin of 30.1%, this company has a higher cost of product (53.3%)
- Midlands Private Neurophysiology Ltd
53.3% - Industry AVG

Profitability
an operating margin of 9.2% make it less profitable than the average company (15%)
- Midlands Private Neurophysiology Ltd
15% - Industry AVG

Employees
with 2 employees, this is below the industry average (13)
2 - Midlands Private Neurophysiology Ltd
13 - Industry AVG

Pay Structure
on an average salary of £30.5k, the company has an equivalent pay structure (£30.5k)
- Midlands Private Neurophysiology Ltd
£30.5k - Industry AVG

Efficiency
resulting in sales per employee of £1.9m, this is more efficient (£72.6k)
- Midlands Private Neurophysiology Ltd
£72.6k - Industry AVG

Debtor Days
it gets paid by customers after 165 days, this is later than average (35 days)
- Midlands Private Neurophysiology Ltd
35 days - Industry AVG

Creditor Days
its suppliers are paid after 64 days, this is slower than average (34 days)
- Midlands Private Neurophysiology Ltd
34 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Midlands Private Neurophysiology Ltd
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Midlands Private Neurophysiology Ltd
- - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 20.9%, this is a lower level of debt than the average (28.1%)
20.9% - Midlands Private Neurophysiology Ltd
28.1% - Industry AVG
MIDLANDS PRIVATE NEUROPHYSIOLOGY LTD financials

Midlands Private Neurophysiology Ltd's latest turnover from March 2024 is estimated at £3.8 million and the company has net assets of £2 million. According to their latest financial statements, Midlands Private Neurophysiology Ltd has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 2 | 2 | 2 | 2 | 2 | 2 | ||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 751,164 | 696,074 | 696,074 | 671,574 | 671,574 | 671,574 | 491,264 | 491,264 | 291 | 581 | ||||
Intangible Assets | ||||||||||||||
Investments & Other | 491,264 | |||||||||||||
Debtors (Due After 1 year) | ||||||||||||||
Total Fixed Assets | 751,164 | 696,074 | 696,074 | 671,574 | 671,574 | 671,574 | 491,264 | 491,264 | 491,264 | 291 | 581 | |||
Stock & work in progress | ||||||||||||||
Trade Debtors | 1,721,838 | 1,345,295 | 1,090,197 | 995,196 | 817,553 | 606,760 | 565,692 | 450,408 | ||||||
Group Debtors | ||||||||||||||
Misc Debtors | ||||||||||||||
Cash | 249,655 | 519,563 | 387,333 | 303,607 | 207,439 | 102,551 | ||||||||
misc current assets | 9 | 29,227 | 25,635 | |||||||||||
total current assets | 1,721,838 | 1,345,295 | 1,090,197 | 995,196 | 817,553 | 606,760 | 565,692 | 450,408 | 249,664 | 548,790 | 412,968 | 303,607 | 207,439 | 102,551 |
total assets | 2,473,002 | 2,041,369 | 1,786,271 | 1,666,770 | 1,489,127 | 1,278,334 | 1,056,956 | 941,672 | 740,928 | 548,790 | 412,968 | 303,898 | 208,020 | 102,551 |
Bank overdraft | ||||||||||||||
Bank loan | ||||||||||||||
Trade Creditors | 471,802 | 345,616 | 287,318 | 424,154 | 358,050 | 332,710 | 250,830 | 241,175 | 200,297 | 131,903 | 99,458 | 64,581 | 45,393 | 28,771 |
Group/Directors Accounts | ||||||||||||||
other short term finances | ||||||||||||||
hp & lease commitments | ||||||||||||||
other current liabilities | ||||||||||||||
total current liabilities | 471,802 | 345,616 | 287,318 | 424,154 | 358,050 | 332,710 | 250,830 | 241,175 | 200,297 | 131,903 | 99,458 | 64,581 | 45,393 | 28,771 |
loans | ||||||||||||||
hp & lease commitments | ||||||||||||||
Accruals and Deferred Income | ||||||||||||||
other liabilities | 45,152 | |||||||||||||
provisions | ||||||||||||||
total long term liabilities | 45,152 | |||||||||||||
total liabilities | 516,954 | 345,616 | 287,318 | 424,154 | 358,050 | 332,710 | 250,830 | 241,175 | 200,297 | 131,903 | 99,458 | 64,581 | 45,393 | 28,771 |
net assets | 1,956,048 | 1,695,753 | 1,498,953 | 1,242,616 | 1,131,077 | 945,624 | 806,126 | 700,497 | 540,631 | 416,887 | 313,510 | 239,317 | 162,627 | 73,780 |
total shareholders funds | 1,956,048 | 1,695,753 | 1,498,953 | 1,242,616 | 1,131,077 | 945,624 | 806,126 | 700,497 | 540,631 | 416,887 | 313,510 | 239,317 | 162,627 | 73,780 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 291 | 290 | 289 | |||||||||||
Amortisation | ||||||||||||||
Tax | ||||||||||||||
Stock | ||||||||||||||
Debtors | 376,543 | 255,098 | 95,001 | 177,643 | 210,793 | 41,068 | 115,284 | 450,408 | ||||||
Creditors | 126,186 | 58,298 | -136,836 | 66,104 | 25,340 | 81,880 | 9,655 | 40,878 | 68,394 | 32,445 | 34,877 | 19,188 | 16,622 | 28,771 |
Accruals and Deferred Income | ||||||||||||||
Deferred Taxes & Provisions | ||||||||||||||
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | -491,264 | 491,264 | ||||||||||||
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | ||||||||||||||
Group/Directors Accounts | ||||||||||||||
Other Short Term Loans | ||||||||||||||
Long term loans | ||||||||||||||
Hire Purchase and Lease Commitments | ||||||||||||||
other long term liabilities | 45,152 | |||||||||||||
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -249,655 | -269,908 | 132,230 | 83,726 | 96,168 | 104,888 | 102,551 | |||||||
overdraft | ||||||||||||||
change in cash | -249,655 | -269,908 | 132,230 | 83,726 | 96,168 | 104,888 | 102,551 |
midlands private neurophysiology ltd Credit Report and Business Information
Midlands Private Neurophysiology Ltd Competitor Analysis

Perform a competitor analysis for midlands private neurophysiology ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in WA14 area or any other competitors across 12 key performance metrics.
midlands private neurophysiology ltd Ownership
MIDLANDS PRIVATE NEUROPHYSIOLOGY LTD group structure
Midlands Private Neurophysiology Ltd has no subsidiary companies.
Ultimate parent company
MIDLANDS PRIVATE NEUROPHYSIOLOGY LTD
07181095
midlands private neurophysiology ltd directors
Midlands Private Neurophysiology Ltd currently has 2 directors. The longest serving directors include Mr Noushad Mytheen (Mar 2010) and Mrs Mini Noushad (Mar 2022).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Noushad Mytheen | England | 62 years | Mar 2010 | - | Director |
Mrs Mini Noushad | England | 57 years | Mar 2022 | - | Director |
P&L
March 2024turnover
3.8m
+28%
operating profit
347.1k
0%
gross margin
30.1%
-3.47%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
2m
+0.15%
total assets
2.5m
+0.21%
cash
0
0%
net assets
Total assets minus all liabilities
midlands private neurophysiology ltd company details
company number
07181095
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
March 2010
age
15
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
J W SCRIVENS & CO LIMITED
auditor
-
address
9 courtney place, bowdon, altrincham, WA14 3QT
Bank
-
Legal Advisor
-
midlands private neurophysiology ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to midlands private neurophysiology ltd.
midlands private neurophysiology ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MIDLANDS PRIVATE NEUROPHYSIOLOGY LTD. This can take several minutes, an email will notify you when this has completed.
midlands private neurophysiology ltd Companies House Filings - See Documents
date | description | view/download |
---|